Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Launched
12mo ago
2025-11-09 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    Nov 9, 2025 · 12mo agoWebsite

Store data

App Store
App Store App Store
Update date not synced
Rating
Rating not syncedRating count not synced
New ratings last mo
—
Price & IAP
FreeIAP data not synced
Current version
—Store metadata

Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct32%
  • Organic Search27%
  • Referrals12%
  • Display Ads8%
  • Other22%

Countries

  • United States64%
  • India31%
  • Canada5%

Search

Domain authority —Domain registered 2025-11-09

KeywordMonthly volume
parlez vous francais1,460
parlez1,440
parlez vous730
app that talks to you in french510
parlez vous français in english410

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-08-08

Key pages

Weekly snapshots
Home
www.parlezvous.app/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does ParlezVous get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ParlezVous and what platforms does it support?
ParlezVous is catalogued under Language Learning: Speak French. Not someday. Today.. Supported platforms: Mobile App.

Related products in this category

Education / Language Learning

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.